ICD10 code of Parsonage-Turner Syndrome and ICD9 code

Parsonage-Turner Syndrome, also known as neuralgic amyotrophy, is classified under ICD-10 code G54.5 (Neuralgic amyotrophy) and was previously identified under ICD-9 code 353.4. These diagnostic codes are essential for medical billing and clinical documentation, though they do not capture the profound physical and emotional challenges faced by the 160 individuals currently sharing their experiences on DiseaseMaps.org.

What is Parsonage-Turner Syndrome?

Parsonage-Turner Syndrome is a rare neurological disorder characterized by the sudden onset of severe pain in the shoulder and upper arm, typically followed by muscle weakness and atrophy as the pain subsides. This condition, often referred to as idiopathic brachial neuritis, typically impacts the brachial plexus—the network of nerves that sends signals from the spinal cord to the shoulder, arm, and hand. Understanding the diagnostic classification via ICD-10 G54.5 helps clinicians track the progress of this complex condition, which often requires a multidisciplinary approach to management.

How is Parsonage-Turner Syndrome diagnosed?

Diagnosis of Parsonage-Turner Syndrome is primarily clinical, meaning it is based on a detailed patient history and physical examination rather than a single definitive test. Because the condition is rare, doctors often use diagnostic codes like G54.5 to rule out other causes of arm pain, such as cervical radiculopathy or rotator cuff injuries. Clinical specialists may utilize the following tools to confirm a diagnosis:

• Electromyography (EMG) and Nerve Conduction Studies: These tests assess the electrical activity of muscles and nerves to identify characteristic patterns of nerve damage.


• Magnetic Resonance Imaging (MRI): High-resolution imaging of the brachial plexus can help visualize nerve enlargement or signal changes.


• Blood tests: These are often performed to rule out systemic inflammatory or autoimmune conditions that can mimic the symptoms of Parsonage-Turner Syndrome.

What is the typical clinical course of Parsonage-Turner Syndrome?

The progression of Parsonage-Turner Syndrome usually follows a predictable, albeit painful, timeline. The initial phase involves intense, often debilitating pain that can last from a few days to several weeks. As the pain begins to recede, patients often notice significant muscle weakness and wasting in the affected areas. While the majority of people with Parsonage-Turner Syndrome experience gradual recovery of muscle strength, this process can take months or even years. Many in our community report that the emotional toll of this recovery period is just as significant as the physical symptoms, highlighting the importance of comprehensive support.

Is there a genetic component to Parsonage-Turner Syndrome?

While most cases are sporadic, some evidence suggests a hereditary form of Parsonage-Turner Syndrome known as Hereditary Neuralgic Amyotrophy (HNA). In these rare instances, the condition is linked to mutations in the SEPT9 gene and follows an autosomal dominant inheritance pattern. However, for the vast majority of patients, the syndrome appears to be an immune-mediated response triggered by viral infections, vaccinations, or surgery. If you suspect a family history, consulting with a genetic counselor can provide clarity on whether your specific case relates to HNA or the more common sporadic form.

Next steps

• Consult with a neurologist or physiatrist who has specific experience with brachial plexus disorders.


• Keep a detailed pain and symptom diary to share during your clinical assessments.


• Join the DiseaseMaps.org community to connect with others who understand the unique journey of living with Parsonage-Turner Syndrome.


• Inquire with your healthcare provider about physical therapy protocols tailored to nerve recovery.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases (GARD) Information Center: Neuralgic amyotrophy.


• Orphanet: Neuralgic amyotrophy (ORPHA:658).


• Online Mendelian Inheritance in Man (OMIM): Hereditary Neuralgic Amyotrophy (#162100).


• World Health Organization (WHO): ICD-10 Version:2019 (G54.5).